BODY WORN INSECT REPELLENT PRODUCTS MARKET ANALYSIS

Regional Analysis

• North America accounted for the largest market share in 2016 in the global body worn insect repellent products market, owing to increasing health awareness and insect bite diseases such as Zika virus and Chagas disease. Increasing awareness in North America regarding Zika virus and its cause is driving growth of the market. According to Centers for Disease Control and Prevention (CDC), around 5,653 Zika virus disease cases were reported in the U.S. in 2015-2018. Furthermore, Chagas disease was mainly found in economies of Latin America and was largely detected in the U.S., Canada, and Europe, owing to population mobility. According to World Health Organization (WHO), in 2015, around 6 to 7 million people were infected worldwide, mostly in Latin America with the parasite causing Chagas disease.
• Asia Pacific is expected to show a significant growth in body worn insect repellent products market over the forecast period. This is attributed to increasing prevalence of diseases associated with insect bite diseases such as mosquito-borne disease, sandfly–borne disease, and snail-transmitted disease. According to National Vector Borne Disease Control Programme (NVBDCP), around 74,454 cases were reported for dengue and 18,639 for chikungunya in India in 2013. Also, Kala-azar is one of the transmitted disease caused by an infected sandfly, which increased from 542 cases in 2016 to 560 cases in 2017 in India, increasing demand for body worn insect repellent products. Furthermore, 70% of malaria cases and 69% malaria deaths were reported in South-East Asia region. As a result of this, government is initiating various programs to control insect-borne diseases. In 2015, World Health Organization (WHO) developed Global Technical Strategy for Malaria 2016-2030 with an objective of eliminating malaria in all economies of the Asia Pacific region by 2030.